Psoriasis: from Pathogenesis to Targeted Therapies
Psoriasis: from Pathogenesis to Targeted Therapies
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Over the last decade, the management of psoriasis has witnessed a paradigm shift. Thanks to the increasing knowledge about the pathogenesis of psoriasis, targeted treatments with monoclonal antibodies have been developed. These antibodies, which target the pathogenic TNF/IL-23/IL-17-pathway, were shown to be safe and efficacious in the management o...
Alternative Titles
Full title
Psoriasis: from Pathogenesis to Targeted Therapies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1989607964
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1989607964
Other Identifiers
ISSN
1080-0549
E-ISSN
1559-0267
DOI
10.1007/s12016-018-8668-1
